HDL, or ‘good’ cholesterol, increased with the folic acid, while LDL, or ‘bad’ cholesterol, decreased with the folic acid.
Read More »Issue 107 Item 10 Efficacy of Orlistat in Overweight Patients With Insulin-Treat
Weight loss improves glycemic control, lipid profiles, and blood pressure in patients with type 2 diabetes.
Read More »Issue 108 Item 9 New Treatment for Early and Pre Type 2 Diabetes
Inhibition of dipeptidyl peptidase IV (DPP IV), could be an early treatment for Type 2 diabetes.
Read More »Issue 109 Item 8 ADA: Acarbose May Delay Development Of Type-2 Diabetes
An international study indicates acarbose could be used to delay the development of Type II diabetes in patients with impaired glucose tolerance.
Read More »Issue 110 Item 7 ADA: Use of a Continuous Glucose Monitoring System to Treat Hyp
CGMS is a useful adjunct in the diagnosis and evaluation of hypoglycemia.
Read More »Issue 111 Item 11 Growth Hormone and Metformin Reduces Fat Mass and CVD Factors
Growth hormone and metformin may be effective treatments for metabolic syndrome.
Read More »Issue 107 Item 9 Oral Contraceptive Use Lowers Blood Glucose and Risk for Diabet
Current use of OCs was associated with lower glucose levels in a racially diverse sample of young women
Read More »Issue 108 Item 8 Retinopathy Associated With Cognitive Impairment
Study shows an independent relationship between retinopathy and cognitive impairment.
Read More »Issue 109 Item 7 ADA: Pramlintide Decreases Glucose Fluctuations in Diabetics Us
Replacement of amylin with pramlintide reduces excessive glucose fluctuations in patients with type 1 diabetes.
Read More »Issue 110 Item 6 ADA: Effectiveness of a Diabetes Educator (DE) in Increasing Ph
DHE presence in a private practice setting was effective at increasing diabetic patient testing compliance for HbA1c, lipids and ALB.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.